Impact of radiotherapy on outcomes of nivolumab in advanced non-small cell lung cancer: a case controlled study Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018
Lung volume reduction surgery in patients with early-stage lung cancer: a single-center study Source: Eur Respir J 2007; 30: Suppl. 51, 433s Year: 2007
The big lung trial (BLT): determining the value of cisplatin-based chemotherapy for all patients with non-small cell lung cancer (NSCLC). Preliminary results in the radical radiotherapy setting Source: Eur Respir J 2003; 22: Suppl. 45, 163s Year: 2003
Radiation therapy for augmenting the efficacy of immunotherapy in advanced non-small cell lung cancer: a case-controlled study Source: ERJ Open Res, 6 (1) 00189-2019; 10.1183/23120541.00189-2019 Year: 2020
Influence of dose of radiotherapy on quality of life in patients with non-small cell lung cancer treated by radiotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 495s Year: 2005
A retrospective study of lung parenchymal damage after neoadjuvant chemo and radiotherapy for non small cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 464s Year: 2002
SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection Source: Eur Respir J, 56 (5) 2000118; 10.1183/13993003.00118-2020 Year: 2020
Estimation of the mediastinal involvement probability in lung cancer: a statistical definition of the clinical target volume for 3-dimensional conformal radiotherapy? Source: Eur Respir J 2002; 20: Suppl. 38, 186s Year: 2002
Clinical impact of irradiated lung volumetric modeling in adjuvant breast radiotherapy (RT) Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012
Our results of stereotactic radiotherapy in advanced stage lung cancer patients Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014
Biological factors predicting response to chemotherapy (CT) in advanced non small cell lung cancer (NSCLC): A feasibility study on the collection of tissue Source: Annual Congress 2010 - The role of biomarkers in lung cancer Year: 2010
Lung function evaluation in gemcitabine and concurrent radiotherapy treatment in nonsmall cell lung cancer (NSCLC) Source: Eur Respir J 2001; 18: Suppl. 33, 376s Year: 2001
Hypofractionated radiotherapy for stage I lung carcinomas: moderate hypofractionation optimizes outcome Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018
Pembrolizumab versus nivolumab as second and further line treatment in non-small cell lung cancer; a retrospective single-centre study Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology Year: 2020
The big lung trial (BLT): a major randomised trial examining the role of cisplatin-based chemotherapy in all stages of non-small cell lung cancer (NSCLC). Preliminary results in the supportive care setting Source: Eur Respir J 2002; 20: Suppl. 38, 399s Year: 2002
Pre-operative chemotherapy in patients with resectable non-small cell lung cancer (NSCLC): the MRC LU22/NVALT/EORTC 08012 multi-centre randomised trial Source: Eur Respir J 2007; 30: Suppl. 51, 240s Year: 2007
Changes of diffusing capacity after neoadjuvant concurrent chemoradiotherapy: implication on postoperative pulmonary complications in non-small cell lung cancer patients Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018
Correlation between parameters of quality of life in patients with non-small cell lung cancer treated by chemotherapy and radiotherapy Source: Annual Congress 2007 - Therapeutic approaches in thoracic oncology Year: 2007
The 7-year results of the surgical treatment of non-small cell lung cancer (NSCLC) patients and the influence of neoadjuvant treatment Source: Annual Congress 2007 - Therapy of thoracic malignancies Year: 2007
Cost-effectiveness analysis of three strategies of erlotinib treatment in non small-cell lung cancer: A prospective multicentric French study (ERMETIC) Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010